RTI Surgical released its first quarter 2018 financial results.
Here are five things to know.
1. The global surgical implant company's worldwide revenues for the first quarter of 2018 were $69.9 million, comparable with first quarter 2017.
2. Revenues were driven by growth in the OEM and International business lines as well as RTI Surgical's acquisition of spine-focused device company Zyga Technology.
3. Growth was partially offset by declines in the company's Sports and Spine lines. Gross profit for the first quarter of 2018 was $33.7 million, or 48.2 percent of revenues, compared to $35.8 million, or 51.2 percent of revenues, in first quarter 2017.
4. Net loss applicable to common shares was $1.9 million in first quarter 2018, or $0.03, compared to a net loss applicable to common shares of $2.8 million in the same period last year.
5. RTI Surgical expects full year revenues between $280 million and $290 million.
More articles on devices and implants:
NuVasive's CEO is preparing for more outpatient spine, less desire for robots: 6 key quotes
Paradigm Spine gets pre-market approval for disposable instrument kit: 4 things to know